Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Vertex Pharmaceuticals patents Na(V) channel inhibitors

Sep. 17, 2012

Research at Actelion yields new P2X7 receptor antagonists

Sep. 17, 2012

Actelion designs novel orexin receptor antagonists

Sep. 17, 2012

Cancer Therapeutics CRC synthesizes novel agents for cancer

Sep. 14, 2012

New antiviral agents patented by German researchers

Sep. 14, 2012

Concert Pharmaceuticals discloses novel deuterated hydroxybutyrate analogues

Sep. 14, 2012

New agents for parasitic infections patented by U.S. team

Sep. 14, 2012

Indian researchers disclose novel agents for cancer

Sep. 14, 2012

Boehringer Ingelheim presents new PDE9A inhibitors

Sep. 14, 2012

Bristol-Myers Squibb discloses new HCV inhibitors

Sep. 13, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...